French launch biotechnology programme:
This article was originally published in Clinica
The French Research Ministry has announced a five-year investment programme to boost France's presence in the world biotechnology sector. France has around 50 biotechnology companies compared with around 1,300 in the US, says a report in Les Echos. The Ministry's programme would provide funding of around Fr 1.5 billion ($300 million) with private investors adding Fr500 million in return with attractive tax breaks.
You may also be interested in...
Medtechs took a long look at themselves as they rose to the challenges of COVID-19. How they responded, repurposed and regrouped to tackle the coronavirus was both sobering and uplifting. The lessons of 2020 must be integrated into the digitally-enabled health care systems of 2021 and beyond.
Top 100 Review: The Calm Before The Storm – But Some Medtechs Already Reflect The Ravages Of COVID-19
2019 saw fewer revenues-boosting major acquisitions by top-tier medtechs. Companies that reported after the calendar year-end were the first to see the consequences of the pandemic on their annual figures.
Hikma and Sesen Bio have struck a deal that will see Hikma distribute the Vicineum brand in the MENA region.